GSK Shingrix Shingles Vaccine Could Get CDC Panel Nod For Use In Immunocompromised Adults

 
• By Brenda Sandburg
Shingrix
GlaxoSmithKline moves to expand Shingrix vaccine for use in immunocompromised adults • Source: Alamy

More from US FDA Performance Tracker

More from Regulatory Trackers